{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-302252","form_type":"8-K/A","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2023-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.835588+00:00","generated_at":"2026-06-07T07:22:00.091319+00:00","sec_items":["9.01","2.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Revolution Medicines issues 54.8M shares for EQRx acquisition; pro forma shows $513M net loss","bullets":["Acquisition closed Nov 8, 2023; issued 54.8M shares valued at ~$1.086B based on $20.02 RVMD price.","EQRx contributed $315.7M cash and $896.6M marketable securities; accounted as capital-raising with asset acquisition.","Pro forma combined cash & securities = $2.01B; net loss for 9M 2023: $513M; FY2022: $443M.","One-time transaction costs of $14M and severance of $11.8M recorded as equity reductions and accruals.","Pro forma EPS $(3.24) for 9M 2023 and $(3.27) for FY2022, on 158.5M and 135.4M weighted shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-302252","json":"https://secwatch.observer/filing/0001193125-23-302252.json","markdown":"https://secwatch.observer/filing/0001193125-23-302252.md","text":"https://secwatch.observer/filing/0001193125-23-302252.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523302252/0001193125-23-302252-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523302252/d613320d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T07:22:00.091319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a538fabc5016628dca86be329878e8fc370e88fe","claim":"Revolution Medicines, Inc. completed an acquisition involving EQRx, Inc. (closed 2023-11-09).","evidence_excerpt":"reporting under Item 2.01 the completion of its previously announced acquisition (the \"Acquisition\") of EQRx, Inc.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523302252/0001193125-23-302252-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"EQRx, Inc."},{"label":"Closing","value":"2023-11-09"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}